# A Study of FDA018-ADC in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct05174637/  
OnCo record `nct05174637` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.

## Summary

A Study of FDA018-ADC in Patients With Advanced Solid Tumors. ClinicalTrials.gov record last updated 2026-01-23: active not recruiting. Enrollment is planned at 78 participants. Primary completion is estimated at 2029-12. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-10-06
- Registry id: NCT05174637
- Phase: 1
- Setting: A Study of FDA018-ADC in Patients With Advanced Solid Tumors
- Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

## Notes

- ClinicalTrials.gov record last updated 2026-01-23: active not recruiting. Enrollment is planned at 78 participants. Primary completion is estimated at 2029-12. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.

## Sources

- ClinicalTrials.gov NCT05174637: https://clinicaltrials.gov/study/NCT05174637

## Connected records

- targets: [TROP2](https://onco.cc/targets/trop2/)
- drugs: [FDA018-ADC](https://onco.cc/drugs/fda018-adc/)

---
JSON: https://onco.cc/api/v1/entities/nct05174637.json